CUMBERLAND PHARMACEUTICALS (CPIX) Stock Price, Quote, News and Overview
NASDAQ:CPIX - Nasdaq - US2307701092 - Common Stock - Currency: USD
CPIX Quote, Performance and Key Statistics
NASDAQ:CPIX (5/21/2025, 8:00:00 PM)
4.96
-0.07 (-1.39%)
The current stock price of CPIX is 4.96 USD. In the past month the price decreased by -4.25%. In the past year, price increased by 220%.
CPIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 52.69 | 687.25B | ||
| JNJ | JOHNSON & JOHNSON | 15.24 | 368.56B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 19.6 | 302.74B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.57 | 222.75B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.73 | 216.03B | ||
| MRK | MERCK & CO. INC. | 9.88 | 193.71B | ||
| PFE | PFIZER INC | 7.18 | 130.67B | ||
| SNY | SANOFI-ADR | 13.88 | 129.50B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.4 | 95.65B | ||
| GSK | GSK PLC-SPON ADR | 7.03 | 77.98B | ||
| ZTS | ZOETIS INC | 26.82 | 72.01B | ||
| HLN | HALEON PLC-ADR | 22.65 | 50.05B |
Related stock screener links
About CPIX
Company Profile
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Company Info
CUMBERLAND PHARMACEUTICALS
2525 West End Avenue, Suite 950
Nashville TENNESSEE 37203 US
CEO: A. J. Kazimi
Employees: 91
Phone: 16152550068
CUMBERLAND PHARMACEUTICALS / CPIX FAQ
What is the stock price of CUMBERLAND PHARMACEUTICALS today?
The current stock price of CPIX is 4.96 USD. The price decreased by -1.39% in the last trading session.
What is the ticker symbol for CUMBERLAND PHARMACEUTICALS stock?
The exchange symbol of CUMBERLAND PHARMACEUTICALS is CPIX and it is listed on the Nasdaq exchange.
On which exchange is CPIX stock listed?
CPIX stock is listed on the Nasdaq exchange.
What is CUMBERLAND PHARMACEUTICALS worth?
CUMBERLAND PHARMACEUTICALS (CPIX) has a market capitalization of 69.29M USD. This makes CPIX a Micro Cap stock.
How many employees does CUMBERLAND PHARMACEUTICALS have?
CUMBERLAND PHARMACEUTICALS (CPIX) currently has 91 employees.
What are the support and resistance levels for CUMBERLAND PHARMACEUTICALS (CPIX) stock?
CUMBERLAND PHARMACEUTICALS (CPIX) has a support level at 4.86 and a resistance level at 4.97. Check the full technical report for a detailed analysis of CPIX support and resistance levels.
Should I buy CUMBERLAND PHARMACEUTICALS (CPIX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CPIX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CPIX, evaluating the profitability, health, valuation and growth aspects
- CUMBERLAND PHARMACEUTICALS (CPIX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CUMBERLAND PHARMACEUTICALS (CPIX) Sales and EPS estimates to see what analysts future expectations are.
- CUMBERLAND PHARMACEUTICALS (CPIX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CUMBERLAND PHARMACEUTICALS (CPIX) Insider and Institutional Ownership to learn about the owners and their transactions.
- CUMBERLAND PHARMACEUTICALS (CPIX) Stock Chart to make your own analysis
- CUMBERLAND PHARMACEUTICALS (CPIX) Latest news and press-releases to stay up to date.
Does CUMBERLAND PHARMACEUTICALS (CPIX) stock pay dividends?
CPIX does not pay a dividend.
When does CUMBERLAND PHARMACEUTICALS (CPIX) report earnings?
CUMBERLAND PHARMACEUTICALS (CPIX) will report earnings on 2025-08-04.
What is the Price/Earnings (PE) ratio of CUMBERLAND PHARMACEUTICALS (CPIX)?
The PE ratio for CUMBERLAND PHARMACEUTICALS (CPIX) is 38.15. This is based on the reported non-GAAP earnings per share of 0.13 and the current share price of 4.96 USD. Check the full fundamental report for a full analysis of the valuation metrics for CPIX.
What is the Short Interest ratio of CUMBERLAND PHARMACEUTICALS (CPIX) stock?
The outstanding short interest for CUMBERLAND PHARMACEUTICALS (CPIX) is 1.11% of its float. Check the ownership tab for more information on the CPIX short interest.
CPIX Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to CPIX. When comparing the yearly performance of all stocks, CPIX is one of the better performing stocks in the market, outperforming 98.36% of all stocks.
CPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CPIX. CPIX has a bad profitability rating. Also its financial health evaluation is rather negative.
CPIX Financial Highlights
Over the last trailing twelve months CPIX reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 550% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.57% | ||
| ROE | -28.35% | ||
| Debt/Equity | 0.45 |
CPIX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to CPIX. The Buy consensus is the average rating of analysts ratings from 6 analysts.